90 related articles for article (PubMed ID: 23455537)
1. Parathyroid hyperplasia shown on (99m)Tc-HYNIC-TOC scan.
Niu N; Mao X; Jing H; Li F
Clin Nucl Med; 2013 Apr; 38(4):294-6. PubMed ID: 23455537
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hyperplasia, thymic carcinoid and pituitary adenoma detected with technetium-99m-MIBI in MEN type I.
Perez-Monte JE; Brown ML; Clarke MR; Watson CG; Carty SE
J Nucl Med; 1997 Nov; 38(11):1767-9. PubMed ID: 9374350
[TBL] [Abstract][Full Text] [Related]
3. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
[TBL] [Abstract][Full Text] [Related]
4. Detection of recurrent pancreatic primitive neuroectodermal tumor by tc-99m hydrazinonicotinyl-tyr3-octreotide scan.
Jing H; Li F; Chen L; Zhang T; Zhao Y
Clin Nucl Med; 2011 Jan; 36(1):54-5. PubMed ID: 21157213
[TBL] [Abstract][Full Text] [Related]
5. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
6. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-HYNIC-TOC (99mTc-hydrazinonicotinyl-Tyr3-octreotide) scintigraphy identifying two separate causative tumors in a patient with tumor-induced osteomalacia (TIO).
Jing H; Li F; Zhong D; Zhuang H
Clin Nucl Med; 2013 Aug; 38(8):664-7. PubMed ID: 23797229
[TBL] [Abstract][Full Text] [Related]
8. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy.
Thomas DL; Bartel T; Menda Y; Howe J; Graham MM; Juweid ME
Clin Nucl Med; 2009 Oct; 34(10):651-5. PubMed ID: 19893394
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of
Chen H; Li Y; Gao X; Shen X
Clin Imaging; 2018; 52():365-369. PubMed ID: 30248495
[TBL] [Abstract][Full Text] [Related]
10. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
12. Osteomalacia-inducing renal clear cell carcinoma uncovered by 99mTc-Hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC) scintigraphy.
Jin X; Jing H; Li F; Zhuang H
Clin Nucl Med; 2013 Nov; 38(11):922-4. PubMed ID: 24089059
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
14. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
Parisella MG; Chianelli M; D'Alessandria C; Todino V; Mikolajczak R; Papini E; Dierckx RA; Scopinaro F; Signore A
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
[TBL] [Abstract][Full Text] [Related]
15. Sestamibi SPECT scintigraphy for detection of postoperative hyperfunctional parathyroid glands.
Schurrer ME; Seabold JE; Gurll NJ; Simonson TM
AJR Am J Roentgenol; 1996 Jun; 166(6):1471-4. PubMed ID: 8633467
[No Abstract] [Full Text] [Related]
16. Increased Uptake of Brown Tumor in 99m Tc-HYNIC-TOC Scintigraphy Mimicking Postoperative Recurrence of Tumor-Induced Osteomalacia.
Zhang Y; Wang P; Liu M; Liu Y; Jing H
Clin Nucl Med; 2023 Nov; 48(11):978-979. PubMed ID: 37703478
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-HYNIC-TOC in the Evaluation of Recurrent Tumor-Induced Osteomalacia.
Shi X; Jing H; Li F; Zhao Y; Wang Z; Huo L
Clin Nucl Med; 2019 Mar; 44(3):209-213. PubMed ID: 30672760
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC.
Artiko V; Sobic-Saranovic D; Pavlovic S; Petrovic M; Zuvela M; Antic A; Matic S; Odalovic S; Petrovic N; Milovanovic A; Obradovic V
J BUON; 2012; 17(3):537-42. PubMed ID: 23033296
[TBL] [Abstract][Full Text] [Related]
19. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
Nguyen BD
Radiographics; 1999; 19(3):601-14; discussion 615-6. PubMed ID: 10336191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
